Akut limfoid leukémia (ALL): vizsgálatok itt: Irán

2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 1/2. fázisTaking people
  Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

  Where

  Tehran

  Életkor

  2 év to 18 év

  People

  5

  Run by

  Kara Yakhteh Tajhiz Azma Company

  See details and how to joinNCT06635330
• 1/2. fázisNot yet taking people in Irán
  Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

  Where

  Tabriz

  Életkor

  3 év and over

  People

  10

  Run by

  Shahid Beheshti University of Medical Sciences

  See details and how to joinNCT06631040